WS
ALNA

Wedbush Securities’s Allena Pharmaceuticals ALNA Stock Holding History

Wedbush Securities’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-24,150
Closed -$36K – 1024
2020
Q3 		$36K Sell
24,150
-25,000
-51% -$35.1K ﹤0.01% 903
2020
Q2 		$78K Buy
49,150
+25,000
+104% +$42K 0.01% 879
2020
Q1 		$23K Sell
24,150
-26,000
-52% -$52K ﹤0.01% 856
2019
Q4 		$137K Buy
50,150
+24,500
+96% +$80.4K 0.01% 905
2019
Q3 		$101K Buy
25,650
+10,250
+67% +$44K 0.01% 896
2019
Q2 		$63K Buy
+15,400
New +$84.1K 0.01% 932

Other funds holding ALNA

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Wedbush Securities's ALNA Position: Q4 2020 in Review

Wedbush Securities sold out of Allena Pharmaceuticals (ALNA) in Q4 2020, closing a stake of 24,150 shares — an estimated $36K sold.

Wedbush Securities first reported a position in ALNA in Q2 2019 and held it in 6 quarters. The position peaked at $137K in Q4 2019. 28 funds tracked by Wall St. Rank hold ALNA as of Q4 2020.

  • Wedbush Securities reported no remaining Allena Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Wedbush Securities sold 24,150 Allena Pharmaceuticals shares in Q4 2020, an estimated $36K.
  • Wedbush Securities first reported a position in Allena Pharmaceuticals in Q2 2019 and held it in 6 quarters.
  • Wedbush Securities's Allena Pharmaceuticals position peaked at $137K in Q4 2019.
  • 28 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q4 2020.

Based on Wedbush Securities's 13F filing for Q4 2020, filed 16 Feb 2021.